SCHEMBL7577550

SCHEMBL7577550

O=C(O)C(Nc1ccc(Cl)cc1F)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.51
PPARA Q07869 3/20 0.51
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
NPC1 O15118 2/20 0.47
HPGD P15428 1/20 0.47
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
POLB P06746 1/20 0.41
GRIK1 P39086 1/20 0.41
ULK1 O75385 1/20 0.41
TAS1R3 Q7RTX0 1/20 0.40
TAS1R1 Q7RTX1 1/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP3A4 P08684 1/20 0.40
MAPT P10636 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7582068 0.85 ULK1 (0.54) RAB9ASMN1; SMN2NPC1KMT2AMEN1
SCHEMBL7583928 0.85 TAS1R3 (0.51) RAB9ANPC1KMT2AMEN1TAS1R3
SCHEMBL3216199 0.84 MEN1 (0.48) PPARGPPARARAB9ASMN1; SMN2NPC1
SCHEMBL7578428 0.82 MAP2K1 (0.44) RAB9ASMN1; SMN2NPC1ULK1ALDH1A1
SCHEMBL7574119 0.82 ALDH1A1 (0.56) RAB9ASMN1; SMN2NPC1HPGDKMT2A
SCHEMBL7577574 0.82 MEN1 (0.48) RAB9ASMN1; SMN2KMT2AMEN1POLB
SCHEMBL16664407 0.81 GAA (0.50) RAB9ASMN1; SMN2NPC1KMT2AMEN1
SCHEMBL2484664 0.81 GAA (0.50) RAB9ASMN1; SMN2NPC1KMT2AMEN1
SCHEMBL13241014 0.81 GAA (0.50) RAB9ASMN1; SMN2NPC1KMT2AMEN1
SCHEMBL7575575 0.81 KCNMA1 (0.54) RAB9ASMN1; SMN2NPC1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242069-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2002-09-25 EP disclosed
WO-2001003684-A2 ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES EXOCELL, INC. (US) 2001-01-18 WO disclosed